nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—ACHE—Physostigmine—glaucoma	0.134	0.176	CbGbCtD
Galantamine—ACHE—Echothiophate—glaucoma	0.134	0.176	CbGbCtD
Galantamine—CHRNA2—Carbachol—glaucoma	0.12	0.157	CbGbCtD
Galantamine—ACHE—Dipivefrin—glaucoma	0.0814	0.107	CbGbCtD
Galantamine—BCHE—Physostigmine—glaucoma	0.0809	0.106	CbGbCtD
Galantamine—BCHE—Echothiophate—glaucoma	0.0809	0.106	CbGbCtD
Galantamine—BCHE—Dipivefrin—glaucoma	0.049	0.0642	CbGbCtD
Galantamine—CYP2D6—Carteolol—glaucoma	0.0165	0.0215	CbGbCtD
Galantamine—CYP2D6—Betaxolol—glaucoma	0.0111	0.0146	CbGbCtD
Galantamine—CYP2D6—Methazolamide—glaucoma	0.00842	0.011	CbGbCtD
Galantamine—CYP3A4—Pilocarpine—glaucoma	0.00793	0.0104	CbGbCtD
Galantamine—CYP2D6—Timolol—glaucoma	0.00716	0.00938	CbGbCtD
Galantamine—CYP3A4—Brinzolamide—glaucoma	0.00622	0.00815	CbGbCtD
Galantamine—CYP2D6—Clonidine—glaucoma	0.00609	0.00797	CbGbCtD
Galantamine—CYP3A4—Dorzolamide—glaucoma	0.00601	0.00787	CbGbCtD
Galantamine—CYP3A4—Methazolamide—glaucoma	0.00536	0.00701	CbGbCtD
Galantamine—CYP3A4—Acetazolamide—glaucoma	0.00428	0.00561	CbGbCtD
Galantamine—CYP3A4—Clonidine—glaucoma	0.00387	0.00507	CbGbCtD
Galantamine—CHRNB2—Circadian rythm related genes—ATOH7—glaucoma	0.00107	0.0353	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000848	0.0279	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000668	0.0219	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000579	0.019	CbGpPWpGaD
Galantamine—CHRNA9—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000567	0.0186	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000495	0.0163	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000472	0.0155	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00047	0.0154	CbGpPWpGaD
Galantamine—CHRNE—ErbB2/ErbB3 signaling events—BAD—glaucoma	0.000465	0.0153	CbGpPWpGaD
Galantamine—CHRNG—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000448	0.0147	CbGpPWpGaD
Galantamine—CHRNA9—Neuronal System—SLC6A13—glaucoma	0.000434	0.0143	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—OPN4—glaucoma	0.000428	0.0141	CbGpPWpGaD
Galantamine—CHRNE—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000421	0.0138	CbGpPWpGaD
Galantamine—CHRNA9—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000415	0.0136	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—SLC6A1—glaucoma	0.000395	0.013	CbGpPWpGaD
Galantamine—CHRNB3—Neuronal System—SLC6A13—glaucoma	0.00038	0.0125	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000363	0.0119	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—SLC6A13—glaucoma	0.00036	0.0118	CbGpPWpGaD
Galantamine—CHRNA6—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000356	0.0117	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000344	0.0113	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—SLC6A13—glaucoma	0.000343	0.0113	CbGpPWpGaD
Galantamine—CHRNG—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000328	0.0108	CbGpPWpGaD
Galantamine—CHRNE—Neuronal System—SLC6A13—glaucoma	0.000323	0.0106	CbGpPWpGaD
Galantamine—CHRNA9—Neuronal System—SLC6A1—glaucoma	0.000318	0.0104	CbGpPWpGaD
Galantamine—CHRNB2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000313	0.0103	CbGpPWpGaD
Galantamine—CHRNE—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000308	0.0101	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000304	0.00999	CbGpPWpGaD
Galantamine—ACHE—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000296	0.00973	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000287	0.00942	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—ACE2—glaucoma	0.00028	0.00921	CbGpPWpGaD
Galantamine—CHRNB3—Neuronal System—SLC6A1—glaucoma	0.000278	0.00913	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—SLC6A13—glaucoma	0.000273	0.00896	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—SLC6A1—glaucoma	0.000263	0.00865	CbGpPWpGaD
Galantamine—CHRNA6—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00026	0.00856	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—SLC6A1—glaucoma	0.000251	0.00826	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—ACE2—glaucoma	0.00025	0.00822	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000249	0.00819	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000247	0.00811	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—SLC6A13—glaucoma	0.00024	0.00789	CbGpPWpGaD
Galantamine—ACHE—Melatonin metabolism and effects—EDN1—glaucoma	0.000239	0.00787	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000239	0.00786	CbGpPWpGaD
Galantamine—CHRNE—Neuronal System—SLC6A1—glaucoma	0.000236	0.00776	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—BAD—glaucoma	0.000234	0.00769	CbGpPWpGaD
Galantamine—CHRNB2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000229	0.00754	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000226	0.00741	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000218	0.00715	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000214	0.00704	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000212	0.00696	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000208	0.00683	CbGpPWpGaD
Galantamine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000202	0.00665	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000201	0.00661	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—SLC6A1—glaucoma	0.0002	0.00656	CbGpPWpGaD
Galantamine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000198	0.0065	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—TGFB2—glaucoma	0.000197	0.00648	CbGpPWpGaD
Galantamine—ACHE—Melatonin metabolism and effects—APOE—glaucoma	0.000195	0.0064	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—SLC6A13—glaucoma	0.000191	0.00627	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—SLC6A13—glaucoma	0.000189	0.00621	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000182	0.00599	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000181	0.00593	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—SLC6A1—glaucoma	0.000176	0.00577	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000175	0.00574	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—SLC6A13—glaucoma	0.000173	0.00568	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000171	0.00563	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000169	0.00556	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000165	0.00543	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—SLC6A13—glaucoma	0.000164	0.00539	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000162	0.00534	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—SLC6A13—glaucoma	0.000162	0.00533	CbGpPWpGaD
Galantamine—Fatigue—Dorzolamide—glaucoma	0.000158	0.000768	CcSEcCtD
Galantamine—Tinnitus—Betaxolol—glaucoma	0.000158	0.000768	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000158	0.000766	CcSEcCtD
Galantamine—Gastrointestinal disorder—Travoprost—glaucoma	0.000158	0.000765	CcSEcCtD
Galantamine—Fatigue—Travoprost—glaucoma	0.000157	0.000764	CcSEcCtD
Galantamine—Cardiac disorder—Betaxolol—glaucoma	0.000157	0.000764	CcSEcCtD
Galantamine—Flushing—Betaxolol—glaucoma	0.000157	0.000764	CcSEcCtD
Galantamine—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000157	0.00517	CbGpPWpGaD
Galantamine—Ill-defined disorder—Clonidine—glaucoma	0.000157	0.000764	CcSEcCtD
Galantamine—CHRNA7—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000157	0.00515	CbGpPWpGaD
Galantamine—Insomnia—Pilocarpine—glaucoma	0.000157	0.000761	CcSEcCtD
Galantamine—Decreased appetite—Brinzolamide—glaucoma	0.000157	0.000761	CcSEcCtD
Galantamine—Weight decreased—Timolol—glaucoma	0.000156	0.00076	CcSEcCtD
Galantamine—Constipation—Travoprost—glaucoma	0.000156	0.000758	CcSEcCtD
Galantamine—Hyperglycaemia—Timolol—glaucoma	0.000156	0.000758	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000156	0.00512	CbGpPWpGaD
Galantamine—Agitation—Clonidine—glaucoma	0.000156	0.000757	CcSEcCtD
Galantamine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000156	0.000756	CcSEcCtD
Galantamine—Paraesthesia—Pilocarpine—glaucoma	0.000155	0.000755	CcSEcCtD
Galantamine—Asthenia—Bimatoprost—glaucoma	0.000155	0.000755	CcSEcCtD
Galantamine—Fatigue—Brinzolamide—glaucoma	0.000155	0.000755	CcSEcCtD
Galantamine—CHRNA1—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000155	0.0051	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—SLC6A13—glaucoma	0.000154	0.00507	CbGpPWpGaD
Galantamine—Somnolence—Pilocarpine—glaucoma	0.000154	0.000748	CcSEcCtD
Galantamine—Depression—Timolol—glaucoma	0.000154	0.000747	CcSEcCtD
Galantamine—Angiopathy—Betaxolol—glaucoma	0.000154	0.000747	CcSEcCtD
Galantamine—Immune system disorder—Betaxolol—glaucoma	0.000153	0.000744	CcSEcCtD
Galantamine—Diarrhoea—Apraclonidine—glaucoma	0.000153	0.000743	CcSEcCtD
Galantamine—Malaise—Clonidine—glaucoma	0.000153	0.000742	CcSEcCtD
Galantamine—Dyspepsia—Pilocarpine—glaucoma	0.000152	0.000741	CcSEcCtD
Galantamine—CHRNB2—Circadian rythm related genes—NGFR—glaucoma	0.000152	0.00501	CbGpPWpGaD
Galantamine—Syncope—Clonidine—glaucoma	0.000152	0.000738	CcSEcCtD
Galantamine—Arrhythmia—Betaxolol—glaucoma	0.000151	0.000735	CcSEcCtD
Galantamine—Feeling abnormal—Dorzolamide—glaucoma	0.000151	0.000734	CcSEcCtD
Galantamine—Decreased appetite—Pilocarpine—glaucoma	0.000151	0.000731	CcSEcCtD
Galantamine—Feeling abnormal—Travoprost—glaucoma	0.00015	0.000731	CcSEcCtD
Galantamine—Gastrointestinal pain—Dorzolamide—glaucoma	0.00015	0.000728	CcSEcCtD
Galantamine—Palpitations—Clonidine—glaucoma	0.00015	0.000727	CcSEcCtD
Galantamine—ACHE—Peptide hormone metabolism—PAX6—glaucoma	0.00015	0.00492	CbGpPWpGaD
Galantamine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000149	0.000726	CcSEcCtD
Galantamine—Gastrointestinal pain—Travoprost—glaucoma	0.000149	0.000725	CcSEcCtD
Galantamine—Loss of consciousness—Clonidine—glaucoma	0.000149	0.000724	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000149	0.00489	CbGpPWpGaD
Galantamine—Feeling abnormal—Brinzolamide—glaucoma	0.000148	0.000721	CcSEcCtD
Galantamine—Mental disorder—Betaxolol—glaucoma	0.000148	0.000721	CcSEcCtD
Galantamine—Constipation—Pilocarpine—glaucoma	0.000148	0.000719	CcSEcCtD
Galantamine—Cough—Clonidine—glaucoma	0.000148	0.000718	CcSEcCtD
Galantamine—Dizziness—Apraclonidine—glaucoma	0.000148	0.000718	CcSEcCtD
Galantamine—Malnutrition—Betaxolol—glaucoma	0.000148	0.000717	CcSEcCtD
Galantamine—CHRNA2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000147	0.00484	CbGpPWpGaD
Galantamine—Epistaxis—Timolol—glaucoma	0.000145	0.000707	CcSEcCtD
Galantamine—Body temperature increased—Dorzolamide—glaucoma	0.000145	0.000704	CcSEcCtD
Galantamine—Abdominal pain—Dorzolamide—glaucoma	0.000145	0.000704	CcSEcCtD
Galantamine—CHRNB2—Circadian rythm related genes—NTRK1—glaucoma	0.000145	0.00476	CbGpPWpGaD
Galantamine—Tension—Betaxolol—glaucoma	0.000145	0.000703	CcSEcCtD
Galantamine—Dysgeusia—Betaxolol—glaucoma	0.000144	0.000702	CcSEcCtD
Galantamine—Chest pain—Clonidine—glaucoma	0.000144	0.000701	CcSEcCtD
Galantamine—Arthralgia—Clonidine—glaucoma	0.000144	0.000701	CcSEcCtD
Galantamine—Abdominal pain—Travoprost—glaucoma	0.000144	0.000701	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—NGF—glaucoma	0.000144	0.00474	CbGpPWpGaD
Galantamine—Anxiety—Clonidine—glaucoma	0.000144	0.000698	CcSEcCtD
Galantamine—Asthenia—Acetazolamide—glaucoma	0.000143	0.000697	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000143	0.00471	CbGpPWpGaD
Galantamine—Dizziness—Bimatoprost—glaucoma	0.000143	0.000696	CcSEcCtD
Galantamine—Nervousness—Betaxolol—glaucoma	0.000143	0.000696	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000143	0.000696	CcSEcCtD
Galantamine—Feeling abnormal—Pilocarpine—glaucoma	0.000143	0.000693	CcSEcCtD
Galantamine—Discomfort—Clonidine—glaucoma	0.000143	0.000692	CcSEcCtD
Galantamine—Vomiting—Apraclonidine—glaucoma	0.000142	0.00069	CcSEcCtD
Galantamine—Muscle spasms—Betaxolol—glaucoma	0.000142	0.000689	CcSEcCtD
Galantamine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000142	0.000688	CcSEcCtD
Galantamine—Hypersensitivity—Brimonidine—glaucoma	0.000141	0.000687	CcSEcCtD
Galantamine—Dry mouth—Clonidine—glaucoma	0.000141	0.000685	CcSEcCtD
Galantamine—Bradycardia—Timolol—glaucoma	0.000141	0.000685	CcSEcCtD
Galantamine—Dermatitis—Apraclonidine—glaucoma	0.000141	0.000684	CcSEcCtD
Galantamine—Headache—Apraclonidine—glaucoma	0.00014	0.00068	CcSEcCtD
Galantamine—CHRND—Neuronal System—SLC6A1—glaucoma	0.00014	0.00459	CbGpPWpGaD
Galantamine—Confusional state—Clonidine—glaucoma	0.000139	0.000677	CcSEcCtD
Galantamine—Vision blurred—Betaxolol—glaucoma	0.000139	0.000675	CcSEcCtD
Galantamine—Rhinitis—Timolol—glaucoma	0.000139	0.000674	CcSEcCtD
Galantamine—CHRNB4—Neuronal System—SLC6A1—glaucoma	0.000138	0.00455	CbGpPWpGaD
Galantamine—Tremor—Betaxolol—glaucoma	0.000138	0.000671	CcSEcCtD
Galantamine—Hallucination—Timolol—glaucoma	0.000138	0.000669	CcSEcCtD
Galantamine—Asthenia—Brimonidine—glaucoma	0.000138	0.000669	CcSEcCtD
Galantamine—Body temperature increased—Pilocarpine—glaucoma	0.000137	0.000665	CcSEcCtD
Galantamine—Abdominal pain—Pilocarpine—glaucoma	0.000137	0.000665	CcSEcCtD
Galantamine—Ill-defined disorder—Betaxolol—glaucoma	0.000137	0.000665	CcSEcCtD
Galantamine—Diarrhoea—Acetazolamide—glaucoma	0.000137	0.000665	CcSEcCtD
Galantamine—Rash—Bimatoprost—glaucoma	0.000137	0.000664	CcSEcCtD
Galantamine—Dermatitis—Bimatoprost—glaucoma	0.000137	0.000663	CcSEcCtD
Galantamine—Oedema peripheral—Timolol—glaucoma	0.000136	0.000663	CcSEcCtD
Galantamine—Anaemia—Betaxolol—glaucoma	0.000136	0.000662	CcSEcCtD
Galantamine—Shock—Clonidine—glaucoma	0.000136	0.000661	CcSEcCtD
Galantamine—Connective tissue disorder—Timolol—glaucoma	0.000136	0.000661	CcSEcCtD
Galantamine—Headache—Bimatoprost—glaucoma	0.000136	0.00066	CcSEcCtD
Galantamine—Nervous system disorder—Clonidine—glaucoma	0.000136	0.000659	CcSEcCtD
Galantamine—Thrombocytopenia—Clonidine—glaucoma	0.000135	0.000658	CcSEcCtD
Galantamine—Hypersensitivity—Dorzolamide—glaucoma	0.000135	0.000656	CcSEcCtD
Galantamine—Tachycardia—Clonidine—glaucoma	0.000135	0.000656	CcSEcCtD
Galantamine—Hypersensitivity—Travoprost—glaucoma	0.000134	0.000653	CcSEcCtD
Galantamine—Skin disorder—Clonidine—glaucoma	0.000134	0.000653	CcSEcCtD
Galantamine—CHRNA4—Neuronal System—SLC6A13—glaucoma	0.000134	0.00439	CbGpPWpGaD
Galantamine—Hyperhidrosis—Clonidine—glaucoma	0.000134	0.000649	CcSEcCtD
Galantamine—BCHE—Peptide hormone metabolism—PAX6—glaucoma	0.000133	0.00438	CbGpPWpGaD
Galantamine—Visual impairment—Timolol—glaucoma	0.000133	0.000648	CcSEcCtD
Galantamine—Malaise—Betaxolol—glaucoma	0.000133	0.000646	CcSEcCtD
Galantamine—Nausea—Apraclonidine—glaucoma	0.000133	0.000645	CcSEcCtD
Galantamine—Hypersensitivity—Brinzolamide—glaucoma	0.000133	0.000645	CcSEcCtD
Galantamine—Vertigo—Betaxolol—glaucoma	0.000133	0.000644	CcSEcCtD
Galantamine—Syncope—Betaxolol—glaucoma	0.000132	0.000643	CcSEcCtD
Galantamine—Dizziness—Acetazolamide—glaucoma	0.000132	0.000642	CcSEcCtD
Galantamine—Anorexia—Clonidine—glaucoma	0.000132	0.00064	CcSEcCtD
Galantamine—Asthenia—Dorzolamide—glaucoma	0.000131	0.000639	CcSEcCtD
Galantamine—Asthenia—Travoprost—glaucoma	0.000131	0.000636	CcSEcCtD
Galantamine—Palpitations—Betaxolol—glaucoma	0.00013	0.000633	CcSEcCtD
Galantamine—Loss of consciousness—Betaxolol—glaucoma	0.00013	0.00063	CcSEcCtD
Galantamine—Eye disorder—Timolol—glaucoma	0.000129	0.000629	CcSEcCtD
Galantamine—Asthenia—Brinzolamide—glaucoma	0.000129	0.000628	CcSEcCtD
Galantamine—Hypotension—Clonidine—glaucoma	0.000129	0.000628	CcSEcCtD
Galantamine—Tinnitus—Timolol—glaucoma	0.000129	0.000627	CcSEcCtD
Galantamine—Cough—Betaxolol—glaucoma	0.000129	0.000625	CcSEcCtD
Galantamine—Nausea—Bimatoprost—glaucoma	0.000129	0.000625	CcSEcCtD
Galantamine—Cardiac disorder—Timolol—glaucoma	0.000128	0.000624	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000128	0.0042	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000128	0.0042	CbGpPWpGaD
Galantamine—Hypersensitivity—Pilocarpine—glaucoma	0.000128	0.00062	CcSEcCtD
Galantamine—Vomiting—Acetazolamide—glaucoma	0.000127	0.000618	CcSEcCtD
Galantamine—Dizziness—Brimonidine—glaucoma	0.000127	0.000617	CcSEcCtD
Galantamine—CHRNA3—Neuronal System—SLC6A1—glaucoma	0.000127	0.00416	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000126	0.000612	CcSEcCtD
Galantamine—Angiopathy—Timolol—glaucoma	0.000126	0.00061	CcSEcCtD
Galantamine—Myalgia—Betaxolol—glaucoma	0.000126	0.00061	CcSEcCtD
Galantamine—Chest pain—Betaxolol—glaucoma	0.000126	0.00061	CcSEcCtD
Galantamine—Arthralgia—Betaxolol—glaucoma	0.000126	0.00061	CcSEcCtD
Galantamine—Diarrhoea—Dorzolamide—glaucoma	0.000125	0.000609	CcSEcCtD
Galantamine—Headache—Acetazolamide—glaucoma	0.000125	0.000609	CcSEcCtD
Galantamine—Anxiety—Betaxolol—glaucoma	0.000125	0.000608	CcSEcCtD
Galantamine—Insomnia—Clonidine—glaucoma	0.000125	0.000608	CcSEcCtD
Galantamine—Immune system disorder—Timolol—glaucoma	0.000125	0.000608	CcSEcCtD
Galantamine—Diarrhoea—Travoprost—glaucoma	0.000125	0.000607	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000125	0.000606	CcSEcCtD
Galantamine—ACHE—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000125	0.00409	CbGpPWpGaD
Galantamine—Asthenia—Pilocarpine—glaucoma	0.000124	0.000604	CcSEcCtD
Galantamine—Paraesthesia—Clonidine—glaucoma	0.000124	0.000603	CcSEcCtD
Galantamine—Discomfort—Betaxolol—glaucoma	0.000124	0.000603	CcSEcCtD
Galantamine—Arrhythmia—Timolol—glaucoma	0.000124	0.000601	CcSEcCtD
Galantamine—Diarrhoea—Brinzolamide—glaucoma	0.000123	0.000599	CcSEcCtD
Galantamine—Somnolence—Clonidine—glaucoma	0.000123	0.000597	CcSEcCtD
Galantamine—Dry mouth—Betaxolol—glaucoma	0.000123	0.000597	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000123	0.00403	CbGpPWpGaD
Galantamine—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000121	0.00399	CbGpPWpGaD
Galantamine—Confusional state—Betaxolol—glaucoma	0.000121	0.00059	CcSEcCtD
Galantamine—Mental disorder—Timolol—glaucoma	0.000121	0.000589	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000121	0.00398	CbGpPWpGaD
Galantamine—Dizziness—Dorzolamide—glaucoma	0.000121	0.000589	CcSEcCtD
Galantamine—Rash—Brimonidine—glaucoma	0.000121	0.000588	CcSEcCtD
Galantamine—Dermatitis—Brimonidine—glaucoma	0.000121	0.000587	CcSEcCtD
Galantamine—Dizziness—Travoprost—glaucoma	0.000121	0.000586	CcSEcCtD
Galantamine—Malnutrition—Timolol—glaucoma	0.000121	0.000585	CcSEcCtD
Galantamine—Headache—Brimonidine—glaucoma	0.00012	0.000584	CcSEcCtD
Galantamine—Decreased appetite—Clonidine—glaucoma	0.00012	0.000584	CcSEcCtD
Galantamine—CHRNA7—Neuronal System—SLC6A1—glaucoma	0.00012	0.00395	CbGpPWpGaD
Galantamine—Gastrointestinal disorder—Clonidine—glaucoma	0.000119	0.00058	CcSEcCtD
Galantamine—Fatigue—Clonidine—glaucoma	0.000119	0.000579	CcSEcCtD
Galantamine—Dizziness—Brinzolamide—glaucoma	0.000119	0.000579	CcSEcCtD
Galantamine—CHRNA1—Neuronal System—SLC6A1—glaucoma	0.000119	0.0039	CbGpPWpGaD
Galantamine—Nausea—Acetazolamide—glaucoma	0.000119	0.000577	CcSEcCtD
Galantamine—Diarrhoea—Pilocarpine—glaucoma	0.000118	0.000576	CcSEcCtD
Galantamine—Shock—Betaxolol—glaucoma	0.000118	0.000575	CcSEcCtD
Galantamine—Tension—Timolol—glaucoma	0.000118	0.000575	CcSEcCtD
Galantamine—Constipation—Clonidine—glaucoma	0.000118	0.000575	CcSEcCtD
Galantamine—Nervous system disorder—Betaxolol—glaucoma	0.000118	0.000574	CcSEcCtD
Galantamine—Dysgeusia—Timolol—glaucoma	0.000118	0.000573	CcSEcCtD
Galantamine—Thrombocytopenia—Betaxolol—glaucoma	0.000118	0.000573	CcSEcCtD
Galantamine—Tachycardia—Betaxolol—glaucoma	0.000117	0.000571	CcSEcCtD
Galantamine—Nervousness—Timolol—glaucoma	0.000117	0.000569	CcSEcCtD
Galantamine—Skin disorder—Betaxolol—glaucoma	0.000117	0.000568	CcSEcCtD
Galantamine—Vomiting—Dorzolamide—glaucoma	0.000117	0.000566	CcSEcCtD
Galantamine—Hyperhidrosis—Betaxolol—glaucoma	0.000116	0.000565	CcSEcCtD
Galantamine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000116	0.00382	CbGpPWpGaD
Galantamine—Rash—Dorzolamide—glaucoma	0.000116	0.000561	CcSEcCtD
Galantamine—Dermatitis—Dorzolamide—glaucoma	0.000115	0.000561	CcSEcCtD
Galantamine—Rash—Travoprost—glaucoma	0.000115	0.000559	CcSEcCtD
Galantamine—Dermatitis—Travoprost—glaucoma	0.000115	0.000558	CcSEcCtD
Galantamine—Headache—Dorzolamide—glaucoma	0.000115	0.000558	CcSEcCtD
Galantamine—Anorexia—Betaxolol—glaucoma	0.000115	0.000558	CcSEcCtD
Galantamine—Vomiting—Brinzolamide—glaucoma	0.000115	0.000557	CcSEcCtD
Galantamine—Dizziness—Pilocarpine—glaucoma	0.000115	0.000556	CcSEcCtD
Galantamine—Headache—Travoprost—glaucoma	0.000114	0.000555	CcSEcCtD
Galantamine—Nausea—Brimonidine—glaucoma	0.000114	0.000554	CcSEcCtD
Galantamine—Feeling abnormal—Clonidine—glaucoma	0.000114	0.000554	CcSEcCtD
Galantamine—Rash—Brinzolamide—glaucoma	0.000114	0.000552	CcSEcCtD
Galantamine—Vision blurred—Timolol—glaucoma	0.000114	0.000552	CcSEcCtD
Galantamine—Dermatitis—Brinzolamide—glaucoma	0.000113	0.000551	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—NGF—glaucoma	0.000113	0.00373	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—FAS—glaucoma	0.000113	0.00373	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000113	0.00373	CbGpPWpGaD
Galantamine—Gastrointestinal pain—Clonidine—glaucoma	0.000113	0.000549	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000113	0.00371	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—SLC6A1—glaucoma	0.000113	0.00371	CbGpPWpGaD
Galantamine—Headache—Brinzolamide—glaucoma	0.000113	0.000548	CcSEcCtD
Galantamine—Hypotension—Betaxolol—glaucoma	0.000112	0.000547	CcSEcCtD
Galantamine—BCHE—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000111	0.00365	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000111	0.00365	CbGpPWpGaD
Galantamine—Vomiting—Pilocarpine—glaucoma	0.00011	0.000535	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00011	0.000533	CcSEcCtD
Galantamine—Abdominal pain—Clonidine—glaucoma	0.000109	0.000531	CcSEcCtD
Galantamine—Body temperature increased—Clonidine—glaucoma	0.000109	0.000531	CcSEcCtD
Galantamine—Rash—Pilocarpine—glaucoma	0.000109	0.00053	CcSEcCtD
Galantamine—Dermatitis—Pilocarpine—glaucoma	0.000109	0.00053	CcSEcCtD
Galantamine—Insomnia—Betaxolol—glaucoma	0.000109	0.000529	CcSEcCtD
Galantamine—Nausea—Dorzolamide—glaucoma	0.000109	0.000529	CcSEcCtD
Galantamine—Headache—Pilocarpine—glaucoma	0.000108	0.000527	CcSEcCtD
Galantamine—Nausea—Travoprost—glaucoma	0.000108	0.000527	CcSEcCtD
Galantamine—Vertigo—Timolol—glaucoma	0.000108	0.000526	CcSEcCtD
Galantamine—Paraesthesia—Betaxolol—glaucoma	0.000108	0.000525	CcSEcCtD
Galantamine—Syncope—Timolol—glaucoma	0.000108	0.000525	CcSEcCtD
Galantamine—Nausea—Brinzolamide—glaucoma	0.000107	0.00052	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000107	0.0035	CbGpPWpGaD
Galantamine—Palpitations—Timolol—glaucoma	0.000106	0.000517	CcSEcCtD
Galantamine—Dyspepsia—Betaxolol—glaucoma	0.000106	0.000515	CcSEcCtD
Galantamine—Loss of consciousness—Timolol—glaucoma	0.000106	0.000515	CcSEcCtD
Galantamine—Cough—Timolol—glaucoma	0.000105	0.000511	CcSEcCtD
Galantamine—Decreased appetite—Betaxolol—glaucoma	0.000105	0.000508	CcSEcCtD
Galantamine—Hypertension—Timolol—glaucoma	0.000104	0.000505	CcSEcCtD
Galantamine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000104	0.000505	CcSEcCtD
Galantamine—Fatigue—Betaxolol—glaucoma	0.000104	0.000504	CcSEcCtD
Galantamine—Constipation—Betaxolol—glaucoma	0.000103	0.0005	CcSEcCtD
Galantamine—Nausea—Pilocarpine—glaucoma	0.000103	0.0005	CcSEcCtD
Galantamine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000103	0.00338	CbGpPWpGaD
Galantamine—Arthralgia—Timolol—glaucoma	0.000103	0.000498	CcSEcCtD
Galantamine—Myalgia—Timolol—glaucoma	0.000103	0.000498	CcSEcCtD
Galantamine—Chest pain—Timolol—glaucoma	0.000103	0.000498	CcSEcCtD
Galantamine—Anxiety—Timolol—glaucoma	0.000102	0.000497	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000102	0.000495	CcSEcCtD
Galantamine—Hypersensitivity—Clonidine—glaucoma	0.000102	0.000495	CcSEcCtD
Galantamine—Discomfort—Timolol—glaucoma	0.000101	0.000492	CcSEcCtD
Galantamine—Dry mouth—Timolol—glaucoma	0.0001	0.000487	CcSEcCtD
Galantamine—Asthenia—Clonidine—glaucoma	9.92e-05	0.000482	CcSEcCtD
Galantamine—Feeling abnormal—Betaxolol—glaucoma	9.92e-05	0.000482	CcSEcCtD
Galantamine—Confusional state—Timolol—glaucoma	9.92e-05	0.000482	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—NGF—glaucoma	9.85e-05	0.00324	CbGpPWpGaD
Galantamine—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	9.82e-05	0.00323	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—NR3C1—glaucoma	9.8e-05	0.00322	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—SLC6A1—glaucoma	9.79e-05	0.00322	CbGpPWpGaD
Galantamine—Shock—Timolol—glaucoma	9.68e-05	0.00047	CcSEcCtD
Galantamine—Nervous system disorder—Timolol—glaucoma	9.64e-05	0.000469	CcSEcCtD
Galantamine—Skin disorder—Timolol—glaucoma	9.55e-05	0.000464	CcSEcCtD
Galantamine—ACHE—Neuronal System—SLC6A13—glaucoma	9.54e-05	0.00313	CbGpPWpGaD
Galantamine—Body temperature increased—Betaxolol—glaucoma	9.52e-05	0.000462	CcSEcCtD
Galantamine—Hyperhidrosis—Timolol—glaucoma	9.51e-05	0.000462	CcSEcCtD
Galantamine—Diarrhoea—Clonidine—glaucoma	9.46e-05	0.00046	CcSEcCtD
Galantamine—Anorexia—Timolol—glaucoma	9.37e-05	0.000455	CcSEcCtD
Galantamine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	9.3e-05	0.00305	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—DHPS—glaucoma	9.22e-05	0.00303	CbGpPWpGaD
Galantamine—Hypotension—Timolol—glaucoma	9.19e-05	0.000447	CcSEcCtD
Galantamine—Dizziness—Clonidine—glaucoma	9.14e-05	0.000444	CcSEcCtD
Galantamine—ACHE—Transmission across Chemical Synapses—SLC6A1—glaucoma	9.11e-05	0.00299	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—BDNF—glaucoma	9.04e-05	0.00297	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Timolol—glaucoma	8.96e-05	0.000435	CcSEcCtD
Galantamine—Insomnia—Timolol—glaucoma	8.9e-05	0.000432	CcSEcCtD
Galantamine—Hypersensitivity—Betaxolol—glaucoma	8.87e-05	0.000431	CcSEcCtD
Galantamine—Paraesthesia—Timolol—glaucoma	8.83e-05	0.000429	CcSEcCtD
Galantamine—ACHE—ATF-2 transcription factor network—MMP2—glaucoma	8.82e-05	0.0029	CbGpPWpGaD
Galantamine—Vomiting—Clonidine—glaucoma	8.79e-05	0.000427	CcSEcCtD
Galantamine—Somnolence—Timolol—glaucoma	8.74e-05	0.000425	CcSEcCtD
Galantamine—Rash—Clonidine—glaucoma	8.72e-05	0.000424	CcSEcCtD
Galantamine—Dermatitis—Clonidine—glaucoma	8.71e-05	0.000423	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1A—glaucoma	8.68e-05	0.00285	CbGpPWpGaD
Galantamine—Headache—Clonidine—glaucoma	8.66e-05	0.000421	CcSEcCtD
Galantamine—Dyspepsia—Timolol—glaucoma	8.66e-05	0.000421	CcSEcCtD
Galantamine—Asthenia—Betaxolol—glaucoma	8.64e-05	0.00042	CcSEcCtD
Galantamine—Decreased appetite—Timolol—glaucoma	8.55e-05	0.000415	CcSEcCtD
Galantamine—BCHE—Neuronal System—SLC6A13—glaucoma	8.51e-05	0.0028	CbGpPWpGaD
Galantamine—Gastrointestinal disorder—Timolol—glaucoma	8.49e-05	0.000413	CcSEcCtD
Galantamine—Fatigue—Timolol—glaucoma	8.48e-05	0.000412	CcSEcCtD
Galantamine—ACHE—Monoamine Transport—TNF—glaucoma	8.33e-05	0.00274	CbGpPWpGaD
Galantamine—Diarrhoea—Betaxolol—glaucoma	8.24e-05	0.0004	CcSEcCtD
Galantamine—BCHE—Metabolism of proteins—DHPS—glaucoma	8.22e-05	0.0027	CbGpPWpGaD
Galantamine—Nausea—Clonidine—glaucoma	8.21e-05	0.000399	CcSEcCtD
Galantamine—BCHE—Transmission across Chemical Synapses—SLC6A1—glaucoma	8.13e-05	0.00267	CbGpPWpGaD
Galantamine—Feeling abnormal—Timolol—glaucoma	8.1e-05	0.000394	CcSEcCtD
Galantamine—Gastrointestinal pain—Timolol—glaucoma	8.04e-05	0.000391	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	8.04e-05	0.00264	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—NGF—glaucoma	8.03e-05	0.00264	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—NR3C1—glaucoma	7.99e-05	0.00263	CbGpPWpGaD
Galantamine—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	7.99e-05	0.00262	CbGpPWpGaD
Galantamine—Dizziness—Betaxolol—glaucoma	7.96e-05	0.000387	CcSEcCtD
Galantamine—Abdominal pain—Timolol—glaucoma	7.77e-05	0.000378	CcSEcCtD
Galantamine—Body temperature increased—Timolol—glaucoma	7.77e-05	0.000378	CcSEcCtD
Galantamine—Vomiting—Betaxolol—glaucoma	7.65e-05	0.000372	CcSEcCtD
Galantamine—Rash—Betaxolol—glaucoma	7.59e-05	0.000369	CcSEcCtD
Galantamine—Dermatitis—Betaxolol—glaucoma	7.58e-05	0.000368	CcSEcCtD
Galantamine—Headache—Betaxolol—glaucoma	7.54e-05	0.000366	CcSEcCtD
Galantamine—Hypersensitivity—Timolol—glaucoma	7.25e-05	0.000352	CcSEcCtD
Galantamine—Nausea—Betaxolol—glaucoma	7.15e-05	0.000347	CcSEcCtD
Galantamine—Asthenia—Timolol—glaucoma	7.06e-05	0.000343	CcSEcCtD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	6.99e-05	0.0023	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—SLC6A1—glaucoma	6.98e-05	0.00229	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—VEGFA—glaucoma	6.88e-05	0.00226	CbGpPWpGaD
Galantamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.79e-05	0.00223	CbGpPWpGaD
Galantamine—Diarrhoea—Timolol—glaucoma	6.73e-05	0.000327	CcSEcCtD
Galantamine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.7e-05	0.0022	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.66e-05	0.00219	CbGpPWpGaD
Galantamine—Dizziness—Timolol—glaucoma	6.5e-05	0.000316	CcSEcCtD
Galantamine—ACHE—Metabolism—CA5A—glaucoma	6.27e-05	0.00206	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NARFL—glaucoma	6.27e-05	0.00206	CbGpPWpGaD
Galantamine—Vomiting—Timolol—glaucoma	6.25e-05	0.000304	CcSEcCtD
Galantamine—BCHE—Neuronal System—SLC6A1—glaucoma	6.23e-05	0.00205	CbGpPWpGaD
Galantamine—Rash—Timolol—glaucoma	6.2e-05	0.000301	CcSEcCtD
Galantamine—Dermatitis—Timolol—glaucoma	6.2e-05	0.000301	CcSEcCtD
Galantamine—Headache—Timolol—glaucoma	6.16e-05	0.000299	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	5.99e-05	0.00197	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.94e-05	0.00195	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—TNF—glaucoma	5.9e-05	0.00194	CbGpPWpGaD
Galantamine—Nausea—Timolol—glaucoma	5.84e-05	0.000284	CcSEcCtD
Galantamine—ACHE—Metabolism of proteins—CTSA—glaucoma	5.75e-05	0.00189	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NARFL—glaucoma	5.59e-05	0.00184	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA5A—glaucoma	5.59e-05	0.00184	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.52e-05	0.00182	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.5e-05	0.00181	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	5.49e-05	0.0018	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.49e-05	0.0018	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—glaucoma	5.42e-05	0.00178	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACE2—glaucoma	5.29e-05	0.00174	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CTSA—glaucoma	5.13e-05	0.00169	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACE2—glaucoma	4.72e-05	0.00155	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.7e-05	0.00155	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	4.7e-05	0.00154	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—glaucoma	4.64e-05	0.00153	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.44e-05	0.00146	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.38e-05	0.00144	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—TP53—glaucoma	4.25e-05	0.0014	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—glaucoma	4.03e-05	0.00132	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.02e-05	0.00132	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.83e-05	0.00126	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTT1—glaucoma	3.67e-05	0.00121	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.6e-05	0.00118	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—glaucoma	3.29e-05	0.00108	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CA1—glaucoma	3.06e-05	0.00101	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CTSA—glaucoma	2.96e-05	0.000974	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.95e-05	0.000971	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	2.92e-05	0.000961	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.88e-05	0.000947	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PAX6—glaucoma	2.82e-05	0.000928	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CA2—glaucoma	2.8e-05	0.00092	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.8e-05	0.000919	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.74e-05	0.000899	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.74e-05	0.000899	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA1—glaucoma	2.73e-05	0.000897	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CTSA—glaucoma	2.65e-05	0.000869	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NARFL—glaucoma	2.57e-05	0.000845	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA5A—glaucoma	2.57e-05	0.000845	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PAX6—glaucoma	2.52e-05	0.000828	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA2—glaucoma	2.5e-05	0.000821	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.44e-05	0.000802	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.44e-05	0.000802	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.4e-05	0.000788	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.34e-05	0.000768	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.33e-05	0.000765	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.3e-05	0.000757	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.99e-05	0.000655	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TXN—glaucoma	1.97e-05	0.000648	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.91e-05	0.000628	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.88e-05	0.000619	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.8e-05	0.000592	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.78e-05	0.000586	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TXN—glaucoma	1.76e-05	0.000578	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.76e-05	0.000578	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA5A—glaucoma	1.68e-05	0.000552	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NARFL—glaucoma	1.68e-05	0.000552	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP1—glaucoma	1.61e-05	0.000528	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.61e-05	0.000528	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.59e-05	0.000523	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTT1—glaucoma	1.53e-05	0.000503	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.53e-05	0.000502	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.51e-05	0.000495	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP1—glaucoma	1.43e-05	0.000471	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTT1—glaucoma	1.36e-05	0.000448	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA1—glaucoma	1.26e-05	0.000413	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—glaucoma	1.24e-05	0.000409	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.23e-05	0.000405	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCA1—glaucoma	1.22e-05	0.0004	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1B1—glaucoma	1.22e-05	0.0004	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CTSA—glaucoma	1.22e-05	0.0004	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA2—glaucoma	1.15e-05	0.000377	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—glaucoma	1.11e-05	0.000365	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.1e-05	0.000362	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1B1—glaucoma	1.09e-05	0.000357	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCA1—glaucoma	1.09e-05	0.000357	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—glaucoma	9.74e-06	0.00032	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—glaucoma	8.69e-06	0.000286	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—glaucoma	8.61e-06	0.000283	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA1—glaucoma	8.21e-06	0.00027	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TXN—glaucoma	8.09e-06	0.000266	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOE—glaucoma	8.02e-06	0.000263	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CTSA—glaucoma	7.95e-06	0.000261	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAV1—glaucoma	7.94e-06	0.000261	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—glaucoma	7.68e-06	0.000252	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA2—glaucoma	7.51e-06	0.000247	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOE—glaucoma	7.15e-06	0.000235	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAV1—glaucoma	7.09e-06	0.000233	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—glaucoma	6.27e-06	0.000206	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NOS3—glaucoma	6.01e-06	0.000197	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—glaucoma	5.49e-06	0.000181	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NOS3—glaucoma	5.36e-06	0.000176	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TXN—glaucoma	5.29e-06	0.000174	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCA1—glaucoma	5e-06	0.000164	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1B1—glaucoma	5e-06	0.000164	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—glaucoma	4.9e-06	0.000161	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—glaucoma	4.1e-06	0.000135	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—glaucoma	4e-06	0.000131	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—glaucoma	3.53e-06	0.000116	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOE—glaucoma	3.29e-06	0.000108	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCA1—glaucoma	3.27e-06	0.000107	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1B1—glaucoma	3.27e-06	0.000107	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAV1—glaucoma	3.26e-06	0.000107	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—glaucoma	2.61e-06	8.59e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NOS3—glaucoma	2.46e-06	8.09e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—glaucoma	2.31e-06	7.59e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—glaucoma	2.25e-06	7.4e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOE—glaucoma	2.15e-06	7.06e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAV1—glaucoma	2.13e-06	7e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NOS3—glaucoma	1.61e-06	5.29e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—glaucoma	1.47e-06	4.84e-05	CbGpPWpGaD
